Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 4 EP applications Lars Sparre Conrad has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 15, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11749331

THERAPEUTIC USES OF 1-[2-(2,4-DIMETHYL-PHENYLSULFANYL)PHENYL]PIPERAZINE

IPC classification:
A61K 31/495, A61P 25/00
Applicant:
H. Lundbeck A/S
Agent:
Lars Sparre Conrad, H. Lundbeck A/S
Status:
PATENT GRANTED
EP12815676

PROCESS FOR THE MANUFACTURE OF 1-[2-(2,4-DIMETHYL-PHENYLSULFANYL)-PHENYL]-PIPERAZINE

IPC classification:
C07D 295/096
Applicant:
H. Lundbeck A/S
Agent:
Lars Sparre Conrad, H. Lundbeck A/S
Status:
GRANT OF PATENT INTENDED
EP13818702

COMPOSITIONS COMPRISING VORTIOXETINE AND DONEPEZIL

IPC classification:
A61K 31/445, A61K 31/495, A61P 25/00, A61P 25/16, A61P 25/24, A61P 25/28
Applicant:
H. Lundbeck A/S
Agent:
Lars Sparre Conrad, H. Lundbeck A/S
Status:
GRANT OF PATENT INTENDED
EP14705524

VORTIOXETINE MANUFACTURING PROCESS

IPC classification:
C07D 295/096
Applicant:
H. Lundbeck A/S
Agent:
Lars Sparre Conrad, H. Lundbeck A/S
Status:
PATENT GRANTED

Please Sign in to use this feature